M. Macpherson
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Shampa Das (5 shared papers)James G. Wright (4 shared papers)Todd Riccobene (3 shared papers)Paul Newell (2 shared papers)Timothy J. Carrothers (2 shared papers)Neil J. Gallagher (3 shared papers)Glen Clack (3 shared papers)Elizabeth B. Lamont (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)European Journal of Clinical Pharmacology (2 papers)Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Expert Opinion on Drug Metabolism & Toxicology (1 paper)
- Partner nations
- United KingdomBelgiumUnited States
In The Last Decade
M. Macpherson
20 papers receiving 467 citations
Peers
Comparison fields: 5 of 57
- Molecular Medicine 116
- Applied Microbiology and Biotechnology 27
- Pharmacology 133
- Oncology 97
- Hematology 32
Countries citing papers authored by M. Macpherson
This map shows the geographic impact of M. Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Macpherson more than expected).
Fields of papers citing papers by M. Macpherson
This network shows the impact of papers produced by M. Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Macpherson. The network helps show where M. Macpherson may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Macpherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 80 | |
| 2 | 2010 | 72 | |
| 3 | 2009 | 44 | |
| 4 | 2018 | 38 | |
| 5 | 2013 | 34 | |
| 6 | 2018 | 28 | |
| 7 | 2011 | 26 | |
| 8 | 2005 | 23 | |
| 9 | 2024 | 21 | |
| 10 | 2022 | 20 | |
| 11 | 2005 | 18 | |
| 12 | 2020 | 17 | |
| 13 | Results of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors | 2013 | 17 |
| 14 | A phase I multiple ascending dose study to assess the safety, tolerability and pharmacokinetics of AZD0530, a highly selective, orally available, dual-specific Src-Abl kinase inhibitor | 2005 | 9 |
| 15 | 2005 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2004 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2004 | 4 | |
| 20 | 2009 | 1 |
About M. Macpherson
M. Macpherson is a scholar working on Molecular Biology, Pharmacology, Genetics, Oncology and Hematology, having authored 21 papers that have together received 477 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Estrogen and related hormone effects (2 papers), Pneumonia and Respiratory Infections (2 papers), Advanced Breast Cancer Therapies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Molecular Medicine (116 citations), Applied Microbiology and Biotechnology (27 citations), Pharmacology (133 citations), Oncology (97 citations) and Hematology (32 citations). M. Macpherson has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Shampa Das, James G. Wright, Todd Riccobene, Paul Newell, Timothy J. Carrothers, Neil J. Gallagher, Glen Clack, Elizabeth B. Lamont, R.A. Seaton and Fátima Cardoso. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Clinical Pharmacology, Cancer Research, Cancer Chemotherapy and Pharmacology and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.